Skip to content

Clinical Study on the Efficacy and Safety of Scalp Active Ingredient Formulation in Individuals with Scalp Seborrheic Dermatitis

Clinical Study on the Efficacy and Safety of Scalp Active Ingredient Formulation in Individuals with Scalp Seborrheic Dermatitis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105234
Enrollment
Unknown
Registered
2025-07-01
Start date
2025-07-09
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seborrheic dermatitis

Interventions

Test group:Use test products according to requirements

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: 1. 18-35 years old, regardless of gender; 2. Clinically diagnosed as a patient with mild to moderate scalp seborrheic dermatitis; 3. Not using antifungal/steroid drugs in the first 4 weeks of enrollment; 4. Understand the research purpose and process, and be able to comprehend; 5. Willing and able to complete the entire experimental study and follow-up schedule;

Exclusion criteria

Exclusion criteria: 1. Pregnancy or planning to become pregnant during the study period, or failure to take effective contraceptive measures; 2. Patients with scalp skin diseases that affect efficacy evaluation, scalp injuries, or other skin lesions requiring topical medication treatment, such as scalp psoriasis, eczema, etc; 3. Patients with immunodeficiency or autoimmune diseases; 4. Clinical evaluation suggests that participants are not suitable for the trial;

Design outcomes

Primary

MeasureTime frame
sebum of scalp;Scalp seborrheic dermatitis severity score;Dandruff adhesion score;

Secondary

MeasureTime frame
Transepidermal water loss rate of scalp;Moisture content of scalp stratum corneum;Scalp PH;Safety assessment;

Countries

China

Contacts

Public ContactWang Xi

West China Hospital, Sichuan University

xierwang@126.com+86 28 8542 2300

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026